MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS

Electrophoretic Separation, Lipoproteins

QUANTIMETRIX CORP.

The following data is part of a premarket notification filed by Quantimetrix Corp. with the FDA for Modification To Lipoprint System, Ldl Subfractions.

Pre-market Notification Details

Device IDK013662
510k NumberK013662
Device Name:MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS
ClassificationElectrophoretic Separation, Lipoproteins
Applicant QUANTIMETRIX CORP. 2005 MANHATTAN BEACH BLVD. Redondo Beach,  CA  90278 -1205
ContactGebhard Neyer
CorrespondentGebhard Neyer
QUANTIMETRIX CORP. 2005 MANHATTAN BEACH BLVD. Redondo Beach,  CA  90278 -1205
Product CodeJHO  
CFR Regulation Number862.1475 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-11-06
Decision Date2002-03-08
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.